Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page

Hansen Medical showcases Magellan robotic system and NorthStar catheter at MEET congress in Italy

Wednesday, 07 Dec 2011 15:31
Magellan robotic system
Magellan robotic system

Hansen Medical showcased its Magellan robotic system at the Multidisciplinary European Endovascular Therapy (MEET) Congress, Rome, Italy (1–3 December 2011). 

The company also exhibited its NorthStar robotic catheter, designed to work with the Magellan robotic system. The NorthStar catheter is designed to simplify and enhance catheter navigation and therapeutic intervention in the peripheral vasculature. The Magellan robotic system and NorthStar robotic catheter are CE-marked and available for sale in Europe. They are 510(k) pending and not available for sale in the United States.

“We are excited to showcase our Magellan robotic system and NorthStar robotic catheter at this foremost exhibition on endovascular therapy, and this is an important event in the initial commercial launch of our new system platform,” said Bruce Barclay, president and CEO of Hansen Medical. “Based on the initial clinical and pre-clinical work and feedback from a number of leading clinicians worldwide, these products have the potential to optimise the way physicians navigate the vasculature. The CE marked system and catheter give physicians maximum flexibility and control through independent distal tip control of a catheter and a sheath as well as through robotic manipulation of a standard guidewire from a centralised, remote workstation. Moreover, this proprietary technology has the ability to provide physicians important clinical benefits by allowing precise and predictable catheter navigation of peripheral vessels.”

The Magellan robotic system and NorthStar robotic catheter are intended to be used to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices.

Last year, the company announced the completion of its first-in-man study in Europe during which 20 endovascular procedures were performed with an earlier version of the Magellan robotic system, demonstrating its potential to allow physicians to treat peripheral vascular disease, while lessening radiation exposure.

Add New Comment

Most popular


Prostatic artery embolization set to “dramatically increase” in Brazil
Friday, 10 Jun 2016
In March 2016, the Brazilian Federal Council of Medicina (Conselho Federal de Medicina CFM), the authority in charge of professional regulation and medical licensing in the area of medicine in the ... Prostatic artery embolization set to “dramatically increase” in Brazil

Modern day stroke intervention: a person is not a programme
Thursday, 02 Jun 2016
Embolectomy for stroke with emergent large vessel occlusion is highly stressful, even for the most experienced interventionalists. It involves working in hostile anatomy, time pressure, moving and ... Modern day stroke intervention: a person is not a programme


Constantinos T Sofocleous
Friday, 10 Jun 2016
“As interventional radiology is established as a free standing specialty, an international outreach ... Constantinos T Sofocleous

Gabriel Bartal
Thursday, 26 Nov 2015
“In the early days, I used to have to cut a 7F plastic tube, make side holes, send it off for ... Gabriel Bartal

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions